Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook

Mizuho Bullish on Horizon Pharma (HZNP) Into Today's Investor Day

November 9, 2015 6:51 AM EST

Horizon Pharma (NASDAQ: HZNP) is hosting its analyst day today at 11:30 and will offer short and long term guidance as it grows increasingly focused on its Orphan franchise. The analyst day will be key to drawing distinctions between Horizon's and Valeant's specialty pharma models. PBMs... More

Guggenheim Shows Increasing Confidence in Horizon Pharma (HZNP) Following 3Q Beat; Reiterates Buy

November 6, 2015 11:10 AM EST

Guggenheim reiterated a Buy rating and $40.00 price target on Horizon Pharma (NASDAQ: HZNP) following the company's 3Q15 earnings report. HZNP reported adjusted diluted 3Q15 EPS of $0.70, $0.29 above consensus. The company also raised its '15 EBITDA guidance to $350MM-$360MM from $265MM-$280MM, consensus was... More